首頁 > 市場調查報告書 > 醫療設備

導管循環系統

市場調查報告書

商品編碼

1764964

歐洲外周栓塞線圈市場預測（2031年）-區域分析-按類型、材料和應用

Europe Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application

出版日期: 2025年04月14日 | 出版商:

The Insight Partners | 英文 117 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2023 年歐洲外周栓塞線圈市場價值為 1.8947 億美元，預計到 2031 年將達到 2.6844 億美元；預計 2023 年至 2031 年的複合年成長率為 4.5%。

癌症發生率上升推動歐洲周邊栓塞線圈市場

大腸直腸癌、攝護腺癌、肺癌和子宮頸癌是最常見的癌症類型。根據世界衛生組織 (WHO) 統計，2022 年全球新增癌症病例約 2,000 萬例，癌症死亡病例約 970 萬例。此外，約有 5,300 萬名癌症患者確診後五年存活率較低。近五分之一的人一生中會罹患癌症；每 9 名男性中就有 1 名，每 12 名女性中就有 1 名死於癌症。根據同一資料來源估計，到 2050 年，全球新增癌症病例將達到約 3,500 萬例，比 2022 年報告的病例數增加 77%。線圈栓塞技術廣泛應用於治療肺癌、肝癌、神經內分泌腫瘤、腎癌和子宮頸癌患者，因為栓塞線圈可以阻斷或阻止血液流向腫瘤或組織異常部位。可拆卸和可推動的栓塞線圈均可用於填充或關閉血管。可推式彈簧圈是一種機械栓塞劑，用於動脈和靜脈，可用於多種用途，包括止血、閉塞動脈瘤和動靜脈瘻管等血管病變，以及重新分配血流以保護非目標血管。使用彈簧圈進行栓塞有助於防止動脈瘤和腫瘤生長，從而降低其對重要器官的傷害。因此，癌症病例的不斷增加帶來了對周邊栓塞彈簧圈的大量需求。

歐洲周邊栓塞線圈市場概況

歐洲外周栓塞線圈市場進一步細分為德國、英國、法國、義大利、西班牙和歐洲其他地區。歐洲在全球外周栓塞線圈市場中佔有重要地位，預計在預測期內將錄得強勁的成長率。該地區市場的成長主要歸因於大腸直腸癌和胃腸道出血病例的激增。根據 GLOBOCAN 2020，德國在 2020 年記錄了約 57,528 例新的結直腸病例（包括 26,654 例女性和 30,874 例男性）；其中近八分之一的病例在臨床評估中顯示大腸（結腸）或直腸癌變。根據美國國立衛生研究院 (NIH) 發布的一篇文章，急性胃腸道出血 (AGIB) 是一種常見的外科問題，在英國每年約有 85,000 例發生，即每 6 分鐘發生 1 例。下消化道出血 (LGIB) 的年發生率為每 10,000 人 87 例。此類患者的住院總死亡率為 3.4% 至 17.8%。目前，當內視鏡手術無法進行或無效時，栓塞術被推薦為急性危及生命的 LGIB 治療的初步步驟。可脫性彈簧圈（可配合或不配合三軸系統）以及液體栓塞劑已被證明比其他栓塞劑更有效。

靜脈曲張（靜脈膨脹、充盈過度）在女性中十分常見，尤其是在孕婦和 65 歲以上的女性中。根據 Statista 統計，2020 年西班牙有超過 50 萬名 65-74 歲女性被診斷出患有靜脈曲張。精索靜脈曲張栓塞治療是一種門診治療，恢復時間極短。在此過程中，會在皮膚上（通常在腹股溝）製造一個小切口。將金屬線圈放入導管，然後引導至精索靜脈曲張的靜脈曲張處。這可以有效地閉合受損的靜脈，並透過健康靜脈的其他路徑將血液流回循環系統。歐洲其他地區包括波蘭、奧地利、瑞士、瑞典、挪威、愛爾蘭、丹麥、比利時和荷蘭等發展中國家。根據全球癌症觀察站的資料，2020 年比利時共診斷出 9,585 例新發大腸直腸癌病例，其中女性 4,150 例，男性 5,435 例。此外，2020 年挪威診斷出近 4,976 例新發大腸直腸癌病例。在瑞士，2020 年診斷出約 4,569 例新發大腸直腸癌病例。大腸直腸癌的常見併發症之一是胃腸道出血 (GIB)，通常與原發性腫瘤糜爛和出血有關。微線圈栓塞是減少胃腸道出血的有效方法。可推式線圈是上、下消化道出血最常使用的栓塞劑。

歐洲周邊栓塞線圈市場收入及預測（2031年）（百萬美元）

歐洲周邊栓塞線圈市場細分

歐洲外周栓塞線圈市場按類型、材料、應用和國家分類。

根據類型，歐洲外周栓塞線圈市場分為可分離線圈和可推動線圈。 2023年，可分離線圈佔據了較大的市佔率。

就材質而言，歐洲周邊栓塞線圈市場主要分為鉑金、鉑金水凝膠以及鉑鎢合金。鉑金在2023年佔據了最大的市場佔有率。

根據應用，歐洲周邊栓塞線圈市場細分為出血和創傷、畸形、腫瘤、內臟動脈瘤、II型內漏和靜脈曲張。出血和創傷領域在2023年佔據了最大的市場。

根據國家/地區，歐洲周邊栓塞線圈市場細分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2023年，德國佔據了歐洲周邊栓塞線圈市場佔有率的主導地位。

Medtronic Plc、Penumbra, Inc.、Balt、Boston Scientific Corp、Cook Medical Holdings LLC、Wallaby Medical、Spartan Micro Inc. 和 Terumo Corp. 是歐洲外周栓塞線圈市場的一些領先公司。

Colorectal, prostate, lung, and cervical cancer are the most common types of cancer. According to the World Health Organization (WHO), ~20 million new cancer cases and 9.7 million cancer-related fatalities were reported in 2022. Moreover, approximately 53 million cancer patients exhibited a five-year survival rate after diagnosis. Nearly 1 in 5 people develop cancer in their lifetime; 1 in 9 men and 1 in 12 women die due to cancer. According to the same source, new cancer cases are estimated to reach the count of ~35 million by 2050, with a 77% increase from the number of cases reported in 2022. The coil embolization technique is widely used to treat patients suffering from lung cancer, liver cancer, neuroendocrine tumors, renal cancer, and cervical cancer, as the embolization coil blocks or stops the flow of blood to a tumor or tissue abnormality. Both detachable and pushable embolizing coils can be used to fill or close blood vessels. The pushable coils are mechanical embolic agents used in arteries and veins for various indications, including controlling bleeding, occluding vascular lesions such as aneurysms and arteriovenous fistulas, and redistributing blood flow to protect non-target vessels. Embolization with coils helps prevent the growth of aneurysms and tumors, thus mitigating their ability to harm essential organs. Thus, the rising prevalence of cancer cases creates a high demand for peripheral embolization coils.

Europe Peripheral Embolization Coils Market Overview

The Europe peripheral embolization coils market is further segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global peripheral embolization coils market and is expected to record a strong growth rate during the forecast period. The market growth in the region is mainly attributed to the burgeoning cases of colorectal cancer and gastrointestinal bleeding. According to GLOBOCAN 2020, Germany recorded ~57,528 new colorectal cases (including 26,654 women and 30,874 men) in 2020; nearly one in eight of these cases show cancerous growth in the large intestine (colon) or rectum in clinical evaluation. According to an article released by the National Institutes of Health (NIH), acute gastrointestinal bleeding (AGIB) is a prevalent surgical problem, accounting for ~85,000 occurrences per year in the UK, i.e., 1 case every 6 minutes. The lower gastrointestinal bleeding (LGIB) has an estimated annual incidence of 87 per 10,000 persons. The overall mortality rate for such patients varies from 3.4% to 17.8% for inpatients. Embolization is currently advocated as the initial step in the treatment of acute, life-threatening LGIB when an endoscopic approach proves to be impossible or ineffective. Detachable coils (with or without a triaxial system), as well as liquid embolic agents, have proven to be more effective than other embolic agents.

Varicose veins (bulging, overfilled veins) are highly common among women, particularly during pregnancy and in women over the age of 65. According to Statista, more than 500,000 women aged 65-74 in Spain were diagnosed with varicose veins in 2020. Varicocele embolization is an outpatient treatment that requires minimal recovery time. During the process, a small nick is made in the skin (typically in the groin). Metal coils are put into the catheter before being guided into the varicocele's varicose veins. This effectively closes up the damaged veins and redirects blood flow back to the circulatory system via a different route through healthy veins. Rest of Europe includes developing countries such as Poland, Austria, Switzerland, Sweden, Norway, Ireland, Denmark, Belgium, and the Netherlands. As per the Global Cancer Observatory data, a total of 9,585 new colorectal cancer cases were diagnosed in Belgium in 2020, including 4,150 cases in women and 5,435 in men. Further, nearly 4,976 new colorectal cancer cases in Norway were diagnosed in 2020. In Switzerland, approximately 4,569 new colorectal cancer cases were diagnosed in 2020. One of the common complications of colorectal cancer is GIB, which is typically related to primary tumor erosion and hemorrhage. Microcoil embolization is an effective method for decreasing GIB. Pushable coils are the most common embolic agent utilized in both upper and lower gastrointestinal hemorrhage.

Europe Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)

Europe Peripheral Embolization Coils Market Segmentation

The Europe peripheral embolization coils market is categorized into type, material, application, and country.

Based on type, the Europe peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.

In terms of material, the Europe peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.

By application, the Europe peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.

Based on country, the Europe peripheral embolization coils market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe peripheral embolization coils market share in 2023.

Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; and Terumo Corp. are some of the leading companies operating in the Europe peripheral embolization coils market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Peripheral Embolization Coils Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Aortic Aneurysm
- 4.1.2 Increase in Incidence of Cancer
4.2 Market Restraints
- 4.2.1 Complications Arising During or After Embolization
4.3 Market Opportunities
- 4.3.1 Expanding Range of Applications of Embolization Coils
4.4 Future Trends
- 4.4.1 Growing Importance of Packing Density
4.5 Impact of Drivers and Restraints:

5. Peripheral Embolization Coils Market - Europe Analysis

5.1 Europe Peripheral Embolization Coils Market Overview
5.2 Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
5.3 Peripheral Embolization Coils Market Forecast Analysis
5.4 Peripheral Embolization Coils Market: Company Positioning

6. Europe Peripheral Embolization Coils Market Analysis - by Product Type

6.1 Overview
6.2 Detachable Coil
- 6.2.1 Overview
- 6.2.2 Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Pushable Coil
- 6.3.1 Overview
- 6.3.2 Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Peripheral Embolization Coils Market Analysis - by Material

7.1 Overview
7.2 Platinum
- 7.2.1 Overview
- 7.2.2 Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Platinum & Hydrogel
- 7.3.1 Overview
- 7.3.2 Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Platinum Tungsten Alloy
- 7.4.1 Overview
- 7.4.2 Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Peripheral Embolization Coils Market Analysis - by Application

8.1 Overview
8.2 Bleedings & Trauma
- 8.2.1 Overview
- 8.2.2 Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Malformations
- 8.3.1 Overview
- 8.3.2 Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Tumors
- 8.4.1 Overview
- 8.4.2 Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Visceral Aneurysms
- 8.5.1 Overview
- 8.5.2 Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Endoleak Type II
- 8.6.1 Overview
- 8.6.2 Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Varicose Veins
- 8.7.1 Overview
- 8.7.2 Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Peripheral Embolization Coils Market - Country Analysis

9.1 Europe: Market Overview
- 9.1.1 Europe: Peripheral Embolization Coils Market Breakdown, by Key Country, 2023 and 2031 (%)
  - 9.1.1.1 Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.1.1 Germany: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.1.2 Germany: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.1.3 Germany: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.2 United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.2.1 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.2.2 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.2.3 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.3 France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.3.1 France: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.3.2 France: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.3.3 France: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.4 Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.4.1 Italy: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.4.2 Italy: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.4.3 Italy: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.5 Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.5.1 Spain: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.5.2 Spain: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.5.3 Spain: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.6 Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.6.1 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.6.2 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.6.3 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Application

10. Peripheral Embolization Coils Market-Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Peripheral Embolization Coils Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Penumbra, Inc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Balt
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Boston Scientific Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Cook Medical Holdings LLC
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Wallaby Medical
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Spartan Micro Inc.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Terumo Corp
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Europe Peripheral Embolization Coils Market Segmentation
Table 2. Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 4. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 5. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 6. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 7. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 8. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 9. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 10. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 11. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 12. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 13. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 14. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 16. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 17. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 18. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 19. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 20. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 21. Recent Inorganic Growth Strategies in the Peripheral Embolization Coils Market
Table 22. Recent Organic Growth Strategies in the Peripheral Embolization Coils Market
Table 23. Glossary of Terms, Peripheral Embolization Coils Market

List Of Figures

Figure 1. Europe Peripheral Embolization Coils Market Segmentation, by Country
Figure 2. Peripheral Embolization Coils Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
Figure 5. Company Positioning
Figure 6. Peripheral Embolization Coils Market Share (%) - by Product Type (2023 and 2031)
Figure 7. Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Peripheral Embolization Coils Market Share (%) - by Material (2023 and 2031)
Figure 10. Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Peripheral Embolization Coils Market Share (%) - by Application (2023 and 2031)
Figure 14. Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Europe: Peripheral Embolization Coils Market, by Key Country - Revenue (2023) (US$ Million)
Figure 21. Europe: Peripheral Embolization Coils Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 22. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 25. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Growth Strategies in the Peripheral Embolization Coils Market